Felix Glang1, Moritz Fabian2, Alex German2, Katrin Khakzar2, Angelika Mennecke2, Frederik Laun3, Burkhard Kasper4, Manuel Schmidt2, Arnd Doerfler2, Klaus Scheffler1,5, and Moritz Zaiss1,2
1High-field Magnetic Resonance Center, Max Planck Institute for Biological Cybernetics, Tübingen, Germany, 2Department of Neuroradiology, University Hospital Erlangen, Erlangen, Germany, 3Institute of Radiology, University Hospital Erlangen, Erlangen, Germany, 4Neurology, Epilepsy Center, University Clinic of Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany, 5Department of Biomedical Magnetic Resonance, Eberhard Karls University Tübingen, Tübingen, Germany
Synopsis
Evaluation of multi-parametric in
vivo CEST MRI often requires complex computational processing for both field inhomogeneity
correction and contrast generation. In this work, linear regression was used to
obtain coefficient vectors that directly map uncorrected 7T spectra to
corrected Lorentzian target parameters by simple linear projection. The method generalizes
from healthy subject training data to unseen test data of both healthy subjects
and tumor patients. The linear projection approach thus integrates correction
of both B0 and B1 inhomogeneity as well as contrast generation in a single fast
and interpretable computation step.
Introduction
Extraction of in vivo CEST parameters
often requires complex mathematical modelling for both field inhomogeneity
correction and contrast generation, e.g. by non-linear curve fitting of Bloch-McConnell1 or
Lorentzian models2–4. These are time-consuming, depend
on initial and boundary conditions and thus remain difficult. Presumably, this
is why simple metrics like asymmetry5, ratios or
linear interpolations of certain points in the Z-spectra6,7 are often
preferred for CEST contrast generation.
In
this work, we address the question of finding the best linear combination of
acquired points in the Z-spectrum to predict a desired target contrast. Such
optimal linear combination weights can be found by linear regression applied to
conventionally evaluated training data. Contrast generation can then be
expressed analogously to a discrete Fourier transform (Figure 1, left column)
as linear projection of the raw acquired data onto the respective weight
vectors (Figure 1, right column).Methods
CEST data were acquired from 6 healthy
subjects and one patient with a brain tumor (glioblastoma
WHO grade 4) after written
informed consent at a MAGNETOM Terra 7T scanner (Siemens Healthcare GmbH,
Erlangen, Germany). All in vivo examinations were approved by the local ethics committee.
Homogeneous Gaussian pre-saturation
(120 pulses, tp=15 ms, td=10 ms) was realized using MIMOSA8. Image readout was a
centric 3D snapshot gradient echo9. 56 non-equidistant frequency offsets at two saturation powers of B1=0.72 μT and 1.00 μT were distributed between -100 and 100 ppm. A normalization
image at -300 ppm was acquired after a relaxation delay of 12s.
Conventional evaluation consisted of
interpolation-based B0 and B1 correction10, PCA denosing11 and 5-pool Lorentzian fitting2–4,12.
Uncorrected
but normalized Z-spectra of both B1 levels together with respective B1 maps from
all voxels of a training dataset were assembled in an input data matrix $$$\mathbf{X}$$$ (#voxels x 110). Lorentzian parameters from
each voxel and the B0 map were likewise assembled in the target data matrix $$$\mathbf{Y}$$$ (#voxels x 17).
Employing a general linear regression model, the matrix
of regression coefficients $$$\hat{\mathbf{B}}$$$ for mapping $$$\mathbf{X}$$$ to $$$\mathbf{Y}$$$ was obtained by solving the ordinary least
squares problem13 $$\hat{\mathbf{B}}=\underset{\mathbf{B}}{\text{arg min}}||\mathbf{Y}-\mathbf{XB}||_F^2=(\mathbf{X}^T \mathbf{X})^{-1}\mathbf{X}^T \mathbf{Y}$$
With that, contrasts for a new dataset can be generated
as simple linear projection via matrix multiplication as $$$\mathbf{Y}_{\text{new}}=\mathbf{X}_{\text{new}}\hat{\mathbf{B}}$$$.Results
Data of 5 healthy subjects were
used to obtain regression coefficients , which
were then applied to a sixth healthy test dataset. The resulting maps in Figure
2 show that for APT, NOE and ssMT contrasts as well as ΔB0, the linear projection results (Figure 2B) preserve
the general contrast of the conventionally obtained ground truth maps (Figure
2A). Difference maps in Figure 2C exhibit localized deviations, which partially
coincide with the MIMOSA transmit field map (Figure 2E).
In
Figure 3, the obtained regression coefficients are shown. Some physically
plausible patterns can be identified: For APT, there are contributions around
+3.5 ppm, but also around -3.5 ppm, where NOE coefficients are highest. For
amines, strongest absolute weighting occurs at 2 ppm. In case of ssMT, strongest
contributions are located far off-resonant at ±100 ppm. The ΔB0
coefficients show complex oscillatory behavior around the water peak.
Next,
generalization of the method to pathology was investigated. The same
coefficients were applied to the glioblastoma patient dataset. Figure 4 shows
the CEST results next to clinical contrasts for this patient. Interestingly,
this tumor did not show typical gadolinium uptake (Figure 4A) as expected for glioblastoma,
still amide CEST (Figure 4D, first row) showed the hyperintensity as reported
previously14. Despite
the regression coefficients being obtained from only healthy subject data, the
linear projection approach generalizes to tumor data and the resulting
maps (Figure 4E) still match the general
contrast of the ground truth Lorentzian fit maps (Figure 4A), although with
lower correlation coefficients (Figure 4G) than in the healthy test case
(Figure 2D). Particularly, the linear projections preserve the amide
hyperintensity in the tumor. Similar observations could be made when applying
the linear projection approach to data from a clinical 3T scanner (results not
shown).Discussion
The linear projection approach
integrates B0 correction, B1 correction and contrast generation into a single
computation step. Both generating and applying the coefficient vectors is fast
(fraction of a second) compared to conventional evaluation (several minutes) or
training of neural networks (several hours).
In
the context of current exploration of neural networks for similar tasks15–18, the
linear transform forms the simplest learning-based approach and by its
linearity allows for direct interpretation (Figure 3) and thus also guidance
for more sophisticated approaches. The proposed approach can thus be considered
as the simplest possible form of ‘explainable AI’19 applied to
CEST MRI.
The linear projection approach can be extended by L1-regularization
based input feature selection (‘CEST-Lasso’), which offers the potential to
accelerate CEST acquisition times significantly20.Conclusion
Multi-parametric CEST contrasts
including field inhomogeneity correction can be well approximated by a simple
linear projection of the acquired uncorrected Z-spectra onto regression
coefficients fitted from conventionally evaluated data. The method translates
from healthy to tumor patient datasets and is fast and interpretable - the
latter being in contrast to neural networks employed for similar purposes. The
proposed approach forms the simplest possible form of ‘explainable AI’.Acknowledgements
Financial support of the Max-Planck Society and ERC Advanced Grant "SpreadMRI", No 834940 is gratefully acknowledged.References
1. Liu D, Zhou J, Xue R, Zuo Z, An J, Wang DJJ.
Quantitative characterization of nuclear overhauser enhancement and amide
proton transfer effects in the human brain at 7 Tesla. Magnetic Resonance in
Medicine 2013;70:1070–108.
2. Zaiss M, Windschuh J, Paech D, et al.
Relaxation-compensated CEST-MRI of the human brain at 7T: Unbiased insight into
NOE and amide signal changes in human glioblastoma. NeuroImage 2015;112:180–188.
3. Goerke S, Soehngen Y, Deshmane A, et al.
Relaxation-compensated APT and rNOE CEST-MRI of human brain tumors at 3 T.
Magnetic Resonance in Medicine 2019;82(2):622-632.
4. Deshmane A, Zaiss M, Lindig T, et al. 3D
gradient echo snapshot CEST MRI with low power saturation for human studies at
3T. Magnetic Resonance in Medicine 2019;81:2412–2423.
5. Guivel-Scharen V, Sinnwell T, Wolff SD, Balaban
RS. Detection of Proton Chemical Exchange between Metabolites and Water in
Biological Tissues. Journal of Magnetic Resonance 1998;133:36–45.
6. Xu J, Zaiss M, Zu Z, et al. On the origins of
chemical exchange saturation transfer (CEST) contrast in tumors at 9.4 T. NMR
in Biomedicine 2014;27:406–416.
7. Jin T, Wang P, Zong X, Kim S-G. MR imaging of the amide-proton transfer effect and
the pH-insensitive nuclear overhauser effect at 9.4 T. Magnetic Resonance in
Medicine 2013;69:760–770.
8. Liebert A, Zaiss M, Gumbrecht R, et al. Multiple interleaved mode saturation (MIMOSA) for
B1+ inhomogeneity mitigation in chemical exchange saturation transfer. Magnetic
Resonance in Medicine 2019;82:693–705.
9. Zaiss M, Ehses P, Scheffler K. Snapshot-CEST:
Optimizing spiral-centric-reordered gradient echo acquisition for fast and
robust 3D CEST MRI at 9.4 T. NMR in Biomedicine 2018;31:e3879.
10. Windschuh J, Zaiss M, Meissner J-E, et al. Correction of B1-inhomogeneities for
relaxation-compensated CEST imaging at 7 T. NMR in Biomedicine 2015;28:529–537.
11. Breitling J, Deshmane A, Goerke S, et al.
Adaptive denoising for chemical exchange saturation transfer MR imaging. NMR in
Biomedicine 2019;0:e4133.
12. Khakzar K. 7 tricks for 7T CEST – improving
reproducibility of multi-pool evaluation. 8th International Workshop on
Chemical Exchange Saturation Transfer Imaging; 2020.
13. Rencher AC, Schaalje GB. Linear models in
statistics. 2nd ed. Hoboken, N.J: Wiley-Interscience; 2008.
14. Paech D, Dreher C, Regnery S, et al.
Relaxation-compensated amide proton transfer (APT) MRI signal intensity is
associated with survival and progression in high-grade glioma patients. Eur
Radiol 2019;29:4957–4967.
15. Zaiss M, Deshmane A, Schuppert M, et al.
DeepCEST: 9.4 T Chemical exchange saturation transfer MRI contrast predicted
from 3 T data – a proof of concept study. Magnetic Resonance in Medicine
2019;81:3901–3914.
16. Glang F, Deshmane A, Prokudin S, et al.
DeepCEST 3T: Robust MRI parameter determination and uncertainty quantification
with neural networks—application to CEST imaging of the human brain at 3T.
Magnetic Resonance in Medicine 2020;84:450–466.
17. Chen
L, Schär M, Chan KWY, et al. In vivo imaging of phosphocreatine with artificial
neural networks. Nat Commun 2020;11:1–10 doi: 10.1038/s41467-020-14874-0.
18. Li Y, Xie D, Cember A, et al. Accelerating
GluCEST imaging using deep learning for B0 correction. Magnetic Resonance in
Medicine 2020;84: 1724– 1733.
19. Samek W, Müller K-R. Towards Explainable
Artificial Intelligence. In: Samek W, Montavon G, Vedaldi A, Hansen LK, Müller
K-R, editors. Explainable AI: Interpreting, Explaining and Visualizing Deep
Learning. Lecture Notes in Computer Science. Springer International
Publishing; 2019. pp. 5–22.
20. Fabian M, Glang F, et al. Reduction of 7T CEST scan time and evaluation by
L1-regularised linear projections. Submitted to the ISMRM Annual Meeting, 2021.